​

Globus Medical (GMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GMED Stock Forecast

Globus Medical (GMED) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $98.88, with a high of $117.00 and a low of $80.00. This represents a 11.93% increase from the last price of $88.34.

$45 $60 $75 $90 $105 $120 High: $117 Avg: $98.88 Low: $80 Last Closed Price: $88.34

GMED Stock Rating

Globus Medical stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (72.22%), 9 Hold (25.00%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 9 26 Strong Sell Sell Hold Buy Strong Buy

GMED Price Target Upside V Benchmarks

TypeNameUpside
StockGlobus Medical11.93%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks11.15%

Price Target Trends

1M3M12M
# Anlaysts1617
Avg Price Target$82.00$95.17$100.71
Last Closing Price$88.34$88.34$88.34
Upside/Downside-7.18%7.73%14.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26375--15
Jul, 26364--13
Jun, 26364--13
May, 26464--14
Apr, 26464--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2026UBS$82.00$78.254.79%-7.18%
Jul 16, 2026Richard NewitterTruist Financial$100.00$80.8523.69%13.20%
Jul 13, 2026Shagun SinghRBC Capital$115.00$79.5344.60%30.18%
Jul 08, 2026BMO Capital$94.00$76.2023.36%6.41%
Jul 08, 2026Stifel Nicolaus$80.00$78.831.48%-9.44%
Jun 15, 2026Piper Sandler$100.00$80.3924.39%13.20%
May 08, 2026Needham$117.00$78.7748.53%32.44%
May 08, 2026Larry BiegelsenWells Fargo$103.00$85.0821.06%16.59%
Feb 25, 2026Richard NewitterTruist Financial$115.00$94.3221.93%30.18%
Jan 30, 2026Needham$112.00$90.2224.14%26.78%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 28, 2026UBSNeutralinitialise
Jul 13, 2026RBC CapitalOutperformOutperformhold
Jul 08, 2026BMO CapitalOutperforminitialise
Jun 09, 2026Piper SandlerOverweightOverweighthold
May 08, 2026NeedhamBuyBuyhold
May 08, 2026Wells FargoOverweightOverweighthold
Jan 30, 2026NeedhamHoldBuyupgrade
Jan 26, 2026Cowen & Co.Buyinitialise
Jan 08, 2026Piper SandlerOverweightOverweighthold
Jan 08, 2026CitigroupMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.48$1.89$1.09$0.76$3.98---
Avg Forecast$2.02$2.03$2.31$2.99$3.43$3.93$4.62$4.89
High Forecast$2.04$2.04$2.34$3.01$3.56$4.55$4.67$4.94
Low Forecast$2.00$2.02$2.28$2.92$3.24$3.13$4.58$4.84
Surprise %-26.73%-6.90%-52.81%-74.58%16.03%---

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$958.10M$1.02B$1.57B$2.52B$2.94B---
Avg Forecast$951.95M$1.02B$1.56B$2.51B$2.67B$2.85B$3.06B$3.32B
High Forecast$957.61M$1.03B$1.57B$2.53B$2.69B$2.85B$3.06B$3.35B
Low Forecast$944.84M$1.02B$1.55B$2.50B$2.66B$2.85B$3.05B$3.30B
Surprise %0.65%-0.20%0.59%0.51%10.01%---

Net Income Forecast

$50M $160M $270M $380M $490M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$149.19M$190.17M$122.87M$102.98M$537.87M---
Avg Forecast$118.77M$156.07M$122.87M$339.44M$389.74M$466.32M$529.89M$560.54M
High Forecast$142.53M$187.28M$147.45M$344.61M$408.46M$521.58M$534.94M$565.80M
Low Forecast$95.02M$124.85M$98.30M$334.27M$371.02M$358.42M$524.83M$555.10M
Surprise %25.61%21.85%--69.66%38.01%---

GMED Forecast FAQ

Is Globus Medical stock a buy?

Globus Medical stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 9 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Globus Medical is a favorable investment for most analysts.

What is Globus Medical's price target?

Globus Medical's price target, set by 36 Wall Street analysts, averages $98.88 over the next 12 months. The price target range spans from $80 at the low end to $117 at the high end, suggesting a potential 11.93% change from the previous closing price of $88.34.

How does Globus Medical stock forecast compare to its benchmarks?

Globus Medical's stock forecast shows a 11.93% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (11.15%).

What is the breakdown of analyst ratings for Globus Medical over the past three months?

  • August 2026: 20.00% Strong Buy, 46.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 23.08% Strong Buy, 46.15% Buy, 30.77% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 23.08% Strong Buy, 46.15% Buy, 30.77% Hold, 0% Sell, 0% Strong Sell.

What is Globus Medical’s EPS forecast?

Globus Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $3.93, marking a -1.26% decrease from the reported $3.98 in 2025. Estimates for the following years are $4.62 in 2027, and $4.89 in 2028.

What is Globus Medical’s revenue forecast?

Globus Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $2.85B, reflecting a -2.99% decrease from the reported $2.94B in 2025. The forecast for 2027 is $3.06B, and $3.32B for 2028.

What is Globus Medical’s net income forecast?

Globus Medical's net income forecast for the fiscal year ending in December 2026 stands at $466.32M, representing a -13.30% decrease from the reported $537.87M in 2025. Projections indicate $529.89M in 2027, and $560.54M in 2028.